Orchid logo


11-50 employees San Francisco, United States
Orchid website screenshot

Orchid provides comprehensive preconception genetic screening services to prospective parents, focusing on identifying the risk of inherited conditions. Utilizing whole-genome analysis, Orchid screens embryos for a wide array of diseases, helping couples select the embryo with the lowest genetic predisposition to family-specific diseases. This startup offers extensive, detailed reports and guidance through consultation with board-certified genetic counselors. Orchid's team comprises world-class experts dedicated to enabling parents to make informed decisions about their future child's health by detecting more genetic risks. Investors support Orchid's mission to enhance preventative health care through advanced genetic science.